Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Principal component analysis
Principal component analysis is a versatile statistical method for reducing a cases-by-
variables data table to its essential features, called principal components. Principal …
variables data table to its essential features, called principal components. Principal …
[HTML][HTML] The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
Hepatology AASLD Publications Hepatology Liver Transplantation Hepatology Communications
Clinical Liver Disease Log in or Register Subscribe to journalSubscribe Get new issue …
Clinical Liver Disease Log in or Register Subscribe to journalSubscribe Get new issue …
[HTML][HTML] Changing epidemiology, global trends and implications for outcomes of NAFLD
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …
disease globally and is currently estimated to affect 38% of the global population. Only a …
Current status and future trends of the global burden of MASLD
L Miao, G Targher, CD Byrne, YY Cao… - Trends in Endocrinology & …, 2024 - cell.com
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most
common chronic liver disease globally, affecting more than a third of the world's adult …
common chronic liver disease globally, affecting more than a third of the world's adult …
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) are the
leading causes of chronic liver disease worldwide. NAFLD and ALD share …
leading causes of chronic liver disease worldwide. NAFLD and ALD share …
the epidemiologic burden of non‐alcoholic fatty liver disease across the world
L Henry, J Paik, ZM Younossi - Alimentary pharmacology & …, 2022 - Wiley Online Library
Background The prevalence of non‐alcoholic fatty liver disease (NAFLD) is increasing in
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …
Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties
Left unaddressed, non-alcoholic fatty liver disease (NAFLD) will continue to have substantial
health, economic and social implications. To address the challenge, a paradigm shift is …
health, economic and social implications. To address the challenge, a paradigm shift is …
Steatotic liver disease: pathophysiology and emerging pharmacotherapies
M Kokkorakis, E Muzurović, Š Volčanšek… - Pharmacological …, 2024 - Elsevier
Steatotic liver disease (SLD) displays a dynamic and complex disease phenotype.
Consequently, the metabolic dysfunction-associated steatotic liver disease …
Consequently, the metabolic dysfunction-associated steatotic liver disease …
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis …
P Danpanichkul, K Suparan, P Dutta, C Kaeosri… - Metabolism, 2024 - Elsevier
Objective Metabolic dysfunction-associated steatotic liver disease (MASLD) and
cardiometabolic conditions affect populations across economic strata. Nevertheless, there …
cardiometabolic conditions affect populations across economic strata. Nevertheless, there …
Cdo1-Camkk2-AMPK axis confers the protective effects of exercise against NAFLD in mice
M Chen, JY Zhu, WJ Mu, HY Luo, Y Li, S Li… - Nature …, 2023 - nature.com
Exercise is an effective non-pharmacological strategy for ameliorating nonalcoholic fatty
liver disease (NAFLD), but the underlying mechanism needs further investigation. Cysteine …
liver disease (NAFLD), but the underlying mechanism needs further investigation. Cysteine …